topper's finally got some new material, page-75

re: big sirtex news-aussie funding reimbursement Also since Sirtex is very far under the radar screen and I think the move up may surprise alot. Remember BTA has a market cap of 275 million and gets only 7% of royalty of a 30 dollar product, and is not yet profitable. Sirtex market cap is 100 million , with a profit and treats patients at 14,000 USD per treatment in a very big potential market, and just got 24 more centers in one day under treatment. I still think BTA is good as it may win its suit with GSK